Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-385-5 | CAS number: 106-32-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test item is not skin sensitising.
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
For this endpoint there are two older supporting human maximisation studies available on ethyl octanoate and three recent key in vitro skin sensitisation tests (in chemico DPRA, in vitro LuSens and in vitro h-CLAT test) on ethyl hexanoate, performed according to OECD guidelines and in compliance to GLP. Read-across (RA) was done from ethyl hexanoate to ethyl octanoate and the results on ethyl hexanoate are used for the classification of ethyl octanoate taking into account the human maximization studies on ethyl octanoate.
DPRA:
The reactivity of ethyl hexanoate towards synthetic cystein or lysine containing peptides was evaluated in the DPRA test according to OECD 442C. The percentage of depletion of cysteine- and lysine-peptides is calculated and used in a prediction model to assign the test item to one of four reactivity classes and discriminate between sensitisers and non-sensitisers.
The mean C- and K-peptide depletion was below 0.0%. Negative depletions are considered to be "zero" for the calculation of the mean peptide depletion. Ethyl hexanoate shows no chemical reactivity in the DPRA under the current test conditions.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate is not a sensitiser.
LuSens:
The keratinocyte activating potential of ethyl hexanoate was evaluated in the LuSens assay according to OECD 442D. Ethyl hexanoate was incubated with a luciferase reporter cell line (LuSens cells) for 48 hours at 37°C and the antioxidant response element (ARE) dependent luciferase activity was measured.
Ethyl hexanoate did not precipitate in the experiment and the acceptance criteria were met. Ethyl hexanoate did not induce a statistical significant increase in luciferase activity in LuSens cells in two consecutive concentrations, while the 70% viability was reached. From this it is concluded that ethyl hexanoate does not have keratinocyte activating potential.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate is not a sensitiser.
h-CLAT:
The potential of ethyl hexanoate to induce cell membrane markers CD86 and CD54 expression was evaluated in the human cell line activation test according to the new OECD 442E TG. Ethyl hexanoate was incubated with the human pro-monocytic cell line THP-1 for 24 hours at 37°C and the membrane markers expression was measured by flow cytometry through staining with FITC labeled anti-human-CD86/anti human CD54 antibody and propidium iodide.
Ethyl hexanoate was tested at concentrations of 566 μg/mL onwards and no precipitates were noticed in any concentration. Relative fluorescence intensity and concurrent relative viability were determined. Ethyl hexanoate induced CD54 expression in THP-1 cells with 83% viability. Therefore, it was concluded that ethyl hexanoate induces dendritic cell activation.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate induces dendritic cell activation.
Human maximisation test (see IUCLID 7.10.4) :
Two human maximisation tests with 25 volunteers were performed with ethyl octanoate to determine the contact-sensitizing potential of the test substance in humans.
In the first study the ages varied from 18 to 50 years and in the second study from 18 to 39 years.
Induction included 5 repeated 48 hour occlusive patch tests on the same skin site with a 24 hour rest period between removal and reapplication of the patch. Following a 2 week rest period after the last induction patch, challenge was done by a 48 -hour occluded patch with the maximum non-irritating concentration of the substance on a slightly irritated skin site. The challenge site was scored after 24 and 48 hours after patch removal and the sensitisation index was noted.
In the first test ethyl octanoate at 2% in petrolatum produced sensitisation reactions in two individuals, while in the second study no sensitisation reactions were observed in any of the volunteers.
Ethyl octanoate should not be considered as sensitiser as it is unlikely that this material would present a danger of contact-sensitization.
Conclusion:
To come to a conclusion the results of the three individual in vitro assays need to be taken together as they reflect the three key events in the adverse outcome pathway (AOP) leading to skin sensitisation. For this reason, a weight of evidence approach is applied for the test battery stating that: 'any two of the three tests determine the overall results, i.e. any two positive results drive the prediction of a sensitiser, while any two negative results drive the prediction of a test substance to be a non-sensitiser'.
Ethyl hexanoate is not peptide reactive, does not activate keratinocytes, however activates dendritic cells. Taking together and applying the evaluation criteria described above, ethyl hexanoate is predicted not to be a skin sensitiser. Due to the read-across strategy it can be concluded that ethyl octanoate is also not a sensitiser. The supporting human maximisation studies on ethyl octanoate confirm the conclusion that ethyl octanoate is not a skin sensitiser.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Regarding the classification of the substance for skin sensitisation the results of the three individual assays of the in vitro skin sensitisation test battery need to be taken together as they reflect three key events in the adverse outcome pathway leading to skin sensitisation. For this reason, a weight of evidence approach is applied for the test battery stating that: 'any two of the three tests determine the overall results, i.e. any two positive results drive the prediction of a sensitiser, while any two negative results drive the prediction of a test substance to be a non-sensitiser'.
Due to the RA strategy it can be stated that ethyl octanoate is not peptide reactive, does not activate keratinocytes, however activates dendritic cells. Applying the evaluation criteria described above, the test substance is predicted not to be a skin sensitiser.
The supporting human maximisation studies on ethyl octanoate confirm the conclusion that ethyl octanoate is not a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.